A bibliometric analysis of atezolizumab in hepatocellular carcinoma
Abstract Background Hepatocellular carcinoma (HCC) is a highly prevalent primary liver cancer, accounting for over 90% of all liver cancer cases worldwide and ranking as the third leading cause of cancer-related deaths. The emergence of molecular targeted therapies has completely transformed the tre...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer
2025-10-01
|
| Serie: | Discover Oncology |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1007/s12672-025-03447-6 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|